BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
BioNTech SE (BNTX) Tops Q4 EPS, Revenue
March 27, 2023 6:53 AM EDTBioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR9.26, EUR1.14 better than the analyst estimate of EUR8.12. Revenue for the quarter came in at EUR4.28 billion versus the consensus estimate of EUR3.78 billion.
GUIDANCE:
Estimated BioNTech COVID-19 vaccine revenues for the 2023... More
